{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:57:39Z","timestamp":1755799059347,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EMR\/2016\/005152"],"award-info":[{"award-number":["EMR\/2016\/005152"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biochi.2025.06.012","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T18:21:02Z","timestamp":1750530062000},"page":"64-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repurposing of propafenone, an FDA approved anti-arrhythmic drug for antileishmanial therapy"],"prefix":"10.1016","volume":"236","author":[{"given":"Anindita","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4656-4499","authenticated-orcid":false,"given":"Pradyot Kumar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lalchhuanawmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neerupudi Kishore","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Faiz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biochi.2025.06.012_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.biochi.2025.06.012_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.biochi.2025.06.012_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/trstmh\/trac100","article-title":"Visceral leishmaniasis in the COVID-19 pandemic era","volume":"117","author":"Paul","year":"2023","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.biochi.2025.06.012_bib4","series-title":"WEEKLY EPIDEMIOLOGICAL RECORD","article-title":"Global leishmaniasis surveillance: 2021, assessing the impact of the COVID-19 pandemic","author":"Ruiz-Postigo","year":"2022"},{"key":"10.1016\/j.biochi.2025.06.012_bib5","article-title":"Leishmania: an urgent need for new treatments","volume":"87","year":"2023","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.biochi.2025.06.012_bib6","first-page":"1385","article-title":"Current and promising novel drug candidates against visceral leishmaniasis","volume":"91","author":"Reguera","year":"2019"},{"issue":"3\u20132","key":"10.1016\/j.biochi.2025.06.012_bib7","first-page":"95","article-title":"[propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)]","volume":"70","author":"Beck","year":"1975","journal-title":"Med. Klin."},{"issue":"6","key":"10.1016\/j.biochi.2025.06.012_bib8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/00005344-198111000-00002","article-title":"Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations","volume":"3","author":"Ledda","year":"1981","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"12","key":"10.1016\/j.biochi.2025.06.012_bib9","first-page":"2084","article-title":"Testing propafenone hydrochloride in the ames salmonella microsome system and in Mammalian cytogenetic systems (bone marrow, spermatogonia)","volume":"30","author":"R\u00f6hrborn","year":"1980","journal-title":"Arzneimittelforschung"},{"issue":"14","key":"10.1016\/j.biochi.2025.06.012_bib10","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/jm00014a031","article-title":"Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance","volume":"38","author":"Chiba","year":"1995","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.biochi.2025.06.012_bib11","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1021\/jm960384x","article-title":"Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance","volume":"39","author":"Ecker","year":"1996","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biochi.2025.06.012_bib12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3565(25)10121-3","article-title":"Potassium channel blocking properties of propafenone in rabbit atrial myocytes","volume":"264","author":"Duan","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.biochi.2025.06.012_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.bjp.0702428","article-title":"Effects of propafenone on K currents in human atrial myocytes","volume":"126","author":"Seki","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biochi.2025.06.012_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115238","article-title":"Drug repurposing of propafenone to discover novel anti-tumor agents by impairing homologous recombination to delay DNA damage recovery of rare disease conjunctival melanoma","volume":"250","author":"Wei","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.biochi.2025.06.012_bib15","first-page":"2245","article-title":"Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction","volume":"7","author":"Zheng","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.biochi.2025.06.012_bib16","first-page":"662","article-title":"Selective killing effect of oxytetracycline, propafenone and metamizole on A549 or Hela cells","volume":"25","author":"Shao","year":"2013","journal-title":"Chin. J. Cancer Res."},{"issue":"21","key":"10.1016\/j.biochi.2025.06.012_bib17","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1021\/jm2005546","article-title":"Optimization of propafenone analogues as antimalarial leads","volume":"54","author":"Lowes","year":"2011","journal-title":"J. Med. Chem."},{"issue":"19\u201320 Suppl 3","key":"10.1016\/j.biochi.2025.06.012_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00508-007-0864-6","article-title":"Characterization of a novel class of antimalarials and its applicability to plasmodial target identification","volume":"119","author":"Tasanor","year":"2007","journal-title":"Wien. Klin. Wochenschr."},{"issue":"10","key":"10.1016\/j.biochi.2025.06.012_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/jcb.29954","article-title":"An integrated virtual screening and drug repurposing strategy for the discovery of new antimalarial drugs against Plasmodium falciparum phosphatidylinositol 3-kinase","volume":"122","author":"Verma","year":"2021","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.biochi.2025.06.012_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1747-0285.2006.00391.x","article-title":"Searching for new antimalarial therapeutics amongst known drugs","volume":"67","author":"Weisman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.biochi.2025.06.012_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070686","article-title":"Antiparasitic properties of cardiovascular agents against human intravascular parasite Schistosoma mansoni","volume":"14","author":"Porto","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.biochi.2025.06.012_bib22","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0026-895X(25)09013-3","article-title":"Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance","volume":"49","author":"Chiba","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.biochi.2025.06.012_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0924-8579(03)00213-9","article-title":"Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast","volume":"22","author":"Schuetzer-Muehlbauer","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biochi.2025.06.012_bib24","first-page":"102","article-title":"Inhibitory effect of propafenone derivatives on Pseudomonas aeruginosa biofilm and pyocyanin production","volume":"148","author":"Petrovic","year":"2019","journal-title":"Srp. Arh. Celok. Lek."},{"issue":"7","key":"10.1016\/j.biochi.2025.06.012_bib25","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1021\/acs.jcim.6b00029","article-title":"Anti-arrhythmic medication propafenone a potential drug for alzheimer's disease inhibiting aggregation of A\u03b2: in silico and in vitro studies","volume":"56","author":"Ngo","year":"2016","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.biochi.2025.06.012_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/mol.63.3.547","article-title":"Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1","volume":"63","author":"Madeja","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"44","key":"10.1016\/j.biochi.2025.06.012_bib27","doi-asserted-by":"crossref","first-page":"33898","DOI":"10.1074\/jbc.M110.159897","article-title":"Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1","volume":"285","author":"Madeja","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biochi.2025.06.012_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s002100000392","article-title":"Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel","volume":"363","author":"Mergenthaler","year":"2001","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.biochi.2025.06.012_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0704784","article-title":"Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine","volume":"136","author":"Paul","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biochi.2025.06.012_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0022-3565(24)29293-4","article-title":"Propafenone modulates potassium channel activities of vascular smooth muscle from rat portal veins","volume":"299","author":"Cogolludo","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.biochi.2025.06.012_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.bjp.0702129","article-title":"Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels","volume":"125","author":"Franqueza","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biochi.2025.06.012_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3346\/jkms.2009.24.1.84","article-title":"Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+","volume":"24","author":"Wang","year":"2009","journal-title":"J. Kor. Med. Sci."},{"issue":"4","key":"10.1016\/j.biochi.2025.06.012_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/aps.2010.234","article-title":"Effects of diltiazem and propafenone on the inactivation and recovery kinetics of fKv1.4 channel currents expressed in xenopus oocytes","volume":"32","author":"Zhang","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.biochi.2025.06.012_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030404","article-title":"Chronic propafenone application increases functional K(IR)2.1 expression in vitro","volume":"16","author":"Li","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.biochi.2025.06.012_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121774","article-title":"Microglial potassium channels: from homeostasis to neurodegeneration","volume":"11","author":"Cocozza","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.biochi.2025.06.012_bib36","doi-asserted-by":"crossref","first-page":"F793","DOI":"10.1152\/ajprenal.2000.279.5.F793","article-title":"Molecular and functional properties of two-pore-domain potassium channels","volume":"279","author":"Lesage","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biochi.2025.06.012_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.611853","article-title":"Voltage-gated potassium channels as regulators of cell death","volume":"8","author":"Bachmann","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.biochi.2025.06.012_bib38","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.4161\/cc.8.21.9888","article-title":"Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle","volume":"8","author":"Blackiston","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biochi.2025.06.012_bib39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fonc.2019.00933","article-title":"Voltage-gated potassium channel Kv1.3 as a target in therapy of cancer","volume":"9","author":"Teisseyre","year":"2019","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.biochi.2025.06.012_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s13205-023-03692-y","article-title":"Insights into Leishmania donovani potassium channel family and their biological functions","volume":"13","author":"Paul","year":"2023","journal-title":"3 Biotech"},{"key":"10.1016\/j.biochi.2025.06.012_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.105922","article-title":"Identification of a novel calcium activated potassium channel from Leishmania donovani and in silico predictions of its antigenic features","volume":"220","author":"Paul","year":"2021","journal-title":"Acta Trop."},{"issue":"1\u20132","key":"10.1016\/j.biochi.2025.06.012_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.biochi.2025.06.012_bib43","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00436-014-3868-y","article-title":"Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani","volume":"113","author":"Singh","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.biochi.2025.06.012_bib44","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/jcb.29944","article-title":"Virtual screening of natural compounds for potential inhibitors of sterol C-24 methyltransferase of Leishmania donovani to overcome leishmaniasis","volume":"122","author":"Rahman","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biochi.2025.06.012_bib45","article-title":"Physiological effects of amiodarone on promastigote and amastigote forms of Leishmania amazonensis","volume":"2011","author":"de Macedo-Silva","year":"2011","journal-title":"Mol. Biol. Int."},{"key":"10.1016\/j.biochi.2025.06.012_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106082","article-title":"Leishmania donovani 6-phosphogluconolactonase: crucial for growth and host infection?","volume":"178","author":"Paul","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.biochi.2025.06.012_bib47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ejmech.2017.08.055","article-title":"Efficacy of a series of alpha-pyrone derivatives against leishmania (L.) infantum and Trypanosoma cruzi","volume":"139","author":"Tempone","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biochi.2025.06.012_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114469","article-title":"Evaluation of antileishmanial potential of the antidepressant escitalopram in Leishmania infantum","volume":"209","author":"Lima","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biochi.2025.06.012_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107139","article-title":"Clotrimazole causes membrane depolarization and induces sub G(0) cell cycle arrest in Leishmania donovani","volume":"252","author":"Paul","year":"2024","journal-title":"Acta Trop."},{"issue":"16","key":"10.1016\/j.biochi.2025.06.012_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200109","article-title":"A core-linker-polyamine (CLP) strategy enables rapid discovery of antileishmanial aminoalkylquinolinecarboxamides that target oxidative stress mechanism","volume":"17","author":"Shah","year":"2022","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.biochi.2025.06.012_bib51","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/AAC.01545-10","article-title":"Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major","volume":"55","author":"Manzano","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2025.06.012_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biochi.2024.02.009","article-title":"Pyridoxal kinase gene deletion leads to impaired growth, deranged redox metabolism and cell cycle arrest in Leishmania donovani","volume":"222","author":"Roy","year":"2024","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.biochi.2025.06.012_bib53","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001850","article-title":"Antifungal activity of propafenone on candida spp. strains: interaction with antifungals and possible mechanism of action","volume":"73","author":"Barbosa","year":"2024","journal-title":"J. Med. Microbiol."},{"issue":"15","key":"10.1016\/j.biochi.2025.06.012_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152314","article-title":"A promising method for the determination of cell viability: the membrane potential cell viability assay","volume":"11","author":"Madorran","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biochi.2025.06.012_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1987.tb11208.x","article-title":"Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres","volume":"90","author":"Delgado","year":"1987","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biochi.2025.06.012_bib56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1476-5381.1985.tb11098.x","article-title":"Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres","volume":"86","author":"Delgado","year":"1985","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biochi.2025.06.012_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00504230","article-title":"Inhibition of vmax of the action potential by propafenone and its voltage-, time- and pH-dependence in Mammalian ventricular myocardium","volume":"315","author":"Kohlhardt","year":"1980","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.biochi.2025.06.012_bib58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(84)90240-1","article-title":"Effect of propafenone on the membrane currents of rabbit sino-atrial node cells","volume":"99","author":"Satoh","year":"1984","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biochi.2025.06.012_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009805","article-title":"Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma","volume":"12","author":"Zhou","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"31","key":"10.1016\/j.biochi.2025.06.012_bib61","doi-asserted-by":"crossref","first-page":"21953","DOI":"10.1074\/jbc.274.31.21953","article-title":"Caspase independent\/dependent regulation of K(+), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis","volume":"274","author":"Bortner","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biochi.2025.06.012_bib62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0167-5699(97)80014-X","article-title":"Mitochondrial control of apoptosis","volume":"18","author":"Kroemer","year":"1997","journal-title":"Immunol. Today"},{"issue":"2","key":"10.1016\/j.biochi.2025.06.012_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1022945107762","article-title":"The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update","volume":"8","author":"Ly","year":"2003","journal-title":"Apoptosis"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908425001257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908425001257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:31:27Z","timestamp":1755617487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908425001257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":62,"alternative-id":["S0300908425001257"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2025.06.012","relation":{},"ISSN":["0300-9084"],"issn-type":[{"type":"print","value":"0300-9084"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of propafenone, an FDA approved anti-arrhythmic drug for antileishmanial therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2025.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}